Clinical Trial Update: A Study on Neoadjuvant Therapy for Her-2 Positive Breast Cancer and the Prognosis by Detecting CTCs [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating neoadjuvant therapy for HER2-positive breast cancer and prognosis based on circulating tumor cells (CTCs).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Hospital Affiliated to Military Medical Science, Beijing | Conditions: Breast Neoplasms | Phase 2 | Status: UNKNOWN